Journal Article

DKFZ-2026-01157

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors.

Hardin, E. C. (First author)DKFZ* ; Stark, S.DKFZ* ; Zinke, C. ; Harting, I. ; Pajtler, K.DKFZ* ; Selt, F.DKFZ* ; Milde, T.DKFZ* ; Fankhauser, L.DKFZ* ; Pfister, S. M.DKFZ* ; Witt, O.DKFZ* ; Bartels, U.DKFZ* ; van Tilburg, C. M. (Last author)DKFZ*

2026
American Society of Clinical Oncology Alexandria, VA

Note: #EA:B310#LA:B310# / #DKTKZFB26# / #NCTZFB26#

---

Contributing Institute(s):

1. KKE Pädiatrische Onkologie (B310)
2. DKTK HD zentral (HD01)
3. B062 Pädiatrische Neuroonkologie (B062)
4. Koordinierungsstelle NCT Heidelberg (HD02)

Research Program(s):

1. 312 - Funktionelle und strukturelle Genomforschung (POF4-312) (POF4-312)

Appears in the scientific report 2026

---

Database coverage:
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---